To delay or not to delay, that is the question for patients with acute lymphoblastic leukemia who do not receive prophylactic cranial irradiation.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 30303521.
- Also identified by DOI 10.1002/cncr.31756 and PMC identifier 6289752.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the impact of delaying diagnostic lumbar puncture and initial intrathecal therapy on treatment outcome of children with newly diagnosed acute lymphoblastic leukemia (ALL) treated without prophylactic cranial irradiation, Yeh and colleagues updated their TPOG-ALL-2002 clinical trial. They found that this treatment strategy reduced the rate of traumatic lumbar puncture with blasts to zero, and tended to improve outcome of patients with a CNS-2 or CNS-3 status based on the event-free survival, the overall survival, and the cumulative risk of CNS relapse, as compared to historical controls.
Medical subject headings
- Antineoplastic Agents
- Precursor Cell Lymphoblastic Leukemia-Lymphoma